Definition
Frozen shoulder, medically known as adhesive capsulitis, is a chronic inflammatory and fibrotic condition of the glenohumeral joint capsule resulting in progressive stiffness, pain, and significant restriction of both active and passive shoulder movements. It is a self-limiting condition but can persist for months to years.
Epidemiology
-
Prevalence: approximately 2–5% in the general population
-
Peak incidence: between 40–60 years of age
-
More common in women
-
Higher risk in individuals with systemic conditions such as diabetes mellitus, thyroid disease, and cardiovascular disease
Etiology
Primary (idiopathic) adhesive capsulitis
-
No clear precipitating cause; often insidious onset
-
Thought to involve chronic low-grade inflammation and fibrosis
Secondary adhesive capsulitis
-
Post-traumatic: after shoulder fracture, dislocation, or soft tissue injury
-
Post-surgical: following rotator cuff repair, mastectomy, or other upper limb surgeries
-
Associated with systemic diseases:
-
Diabetes mellitus (type 1 or type 2)
-
Hypothyroidism or hyperthyroidism
-
Cardiovascular disease
-
Parkinson’s disease
-
Pathophysiology
-
Inflammatory process involving the synovium and joint capsule
-
Fibroblastic proliferation and thickening of the capsule
-
Contraction of the capsule and loss of the axillary recess
-
Adhesions form between the capsule and humeral head, limiting motion
Clinical Presentation
Symptoms:
-
Gradual onset shoulder pain, often poorly localised
-
Pain aggravated by movement and at night (disturbs sleep)
-
Progressive stiffness and limitation of both active and passive range of motion
-
Difficulty with overhead activities and behind-the-back movements
Signs:
-
Global restriction in range of motion, especially external rotation
-
Tenderness around the deltoid and bicipital groove
-
No signs of arthritis on radiographs (normal joint space)
Natural History – Three Stages
-
Freezing (painful) stage – 2–9 months
-
Progressive pain, especially at night
-
Increasing stiffness
-
-
Frozen (stiff) stage – 4–12 months
-
Pain gradually decreases
-
Marked stiffness persists
-
Daily activities significantly affected
-
-
Thawing (resolution) stage – 6–24 months
-
Gradual improvement in range of motion
-
Pain minimal or absent
-
Diagnosis
Clinical diagnosis based on history and examination:
-
Restriction of both active and passive range of motion
-
Normal X-ray or MRI (to rule out other causes)
Imaging:
-
X-ray: usually normal (may exclude arthritis or calcific tendinitis)
-
MRI: thickening of coracohumeral ligament, capsule, and rotator interval; decreased axillary pouch volume
Management
Treatment aims to relieve pain, restore movement, and shorten disease duration.
1. Patient Education
-
Explanation of natural history and self-limiting nature
-
Importance of physiotherapy and compliance with home exercise programs
2. Analgesia and Anti-inflammatory Medication
-
Paracetamol: 500–1000 mg orally every 4–6 hours as needed (max 4 g/day)
-
NSAIDs (if no contraindications):
-
Ibuprofen 400–600 mg orally every 8 hours
-
Diclofenac 50 mg orally 2–3 times daily
-
Naproxen 500 mg orally twice daily
-
-
Topical NSAIDs: diclofenac gel applied to the shoulder up to 3–4 times daily
3. Intra-articular Corticosteroid Injections
Most effective in the early freezing stage for pain relief.
-
Triamcinolone acetonide 20–40 mg intra-articularly, single injection (may repeat after 6 weeks if needed)
-
Methylprednisolone acetate 40 mg intra-articularly as alternative
-
Always combined with physiotherapy for best outcomes
4. Physiotherapy
Essential throughout all stages:
-
Passive and active-assisted range of motion exercises
-
Pendulum exercises
-
Capsular stretching and mobilisation
-
Gradual strengthening as mobility returns
-
Home exercise program 2–3 times daily
5. Oral Corticosteroids (Short Course)
For severe early pain and inflammation when injections are not suitable:
-
Prednisolone 15–30 mg orally once daily for 2–3 weeks, taper gradually
6. Other Interventions
-
Hydrodilatation (distension arthrography): injection of saline + steroid into the joint capsule under imaging guidance to stretch the capsule
-
Manipulation under anaesthesia (MUA): reserved for refractory cases; performed under general anaesthesia
-
Arthroscopic capsular release: surgical option for persistent severe restriction after >6 months of conservative therapy
Prognosis
-
Most patients recover within 12–36 months, though mild stiffness may persist in some cases
-
Early intervention with corticosteroid injections and physiotherapy can shorten the course
-
Higher recurrence and prolonged disease in diabetics
No comments:
Post a Comment